Valuation: Pathkey.AI Ltd

Market Cap 21.61M 15.21M 13.65M 12.62M 11.43M 21.35M 1.45B 151M 60.09M 758M 57.08M 55.87M 2.41B P/E 2025
-3.77x
P/E 2026 -8.1x
Enterprise Value 18.2M 12.81M 11.49M 10.63M 9.62M 17.98M 1.22B 127M 50.6M 638M 48.07M 47.06M 2.03B EV / Sales 2025
21.1x
EV / Sales 2026 1,648x
Free-Float
17.5%
Yield 2025 *
-
Yield 2026 -
1 week-11.11%
Current month-40.74%
1 month-38.46%
3 months-40.74%
6 months-69.23%
1 week 0.02
Extreme 0.015
0.02
1 month 0.02
Extreme 0.015
0.03
Current year 0.02
Extreme 0.015
0.08
1 year 0.01
Extreme 0.014
0.08
3 years 0.01
Extreme 0.014
0.08
5 years 0.01
Extreme 0.014
0.15
10 years 0.01
Extreme 0.014
2.4
Manager TitleAgeSince
Chief Executive Officer - 2026-05-10
Chief Tech/Sci/R&D Officer - 1994-01-16
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 2025-10-20
Director/Board Member - 2025-10-20
Chairman - 2025-11-25
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-11.11%-20.00%-63.64% 15.21M
+0.08%+4.05%+26.09%+62.16% 260B
+0.73%+2.25%+9.77%+26.92% 165B
+0.43%+0.35%-17.15%+72.31% 154B
-1.24%-8.32%-57.95%-15.72% 61.49B
+2.54%+3.89%+13.19%+50.09% 52.9B
+0.31%+2.08%-13.62%-6.86% 52.84B
-2.16%-3.58%+8.49%+63.45% 51.46B
-0.53%+3.80%+26.05%+78.41% 51.16B
+0.40%+5.09%+39.40%+102.28% 46.85B
Average +0.07%+0.09%+1.43%+36.94% 89.57B
Weighted average by Cap. +0.20%+1.41%+6.47%+50.39%

Financials

2025 2026
Net sales 322K 227K 203K 188K 170K 318K 21.59M 2.25M 895K 11.3M 851K 833K 35.86M 47.63K 33.53K 30.08K 27.81K 25.19K 47.06K 3.19M 333K 132K 1.67M 126K 123K 5.31M
Net income -1.45M -1.02M -914K -845K -766K -1.43M -97.07M -10.11M -4.03M -50.79M -3.82M -3.74M -161M -3.65M -2.57M -2.31M -2.13M -1.93M -3.61M -245M -25.5M -10.16M -128M -9.65M -9.45M -407M
Net Debt -25.17K -17.72K -15.9K -14.7K -13.31K -24.87K -1.69M -176K -69.98K -883K -66.48K -65.08K -2.8M -3.41M -2.4M -2.15M -1.99M -1.8M -3.37M -229M -23.81M -9.48M -120M -9.01M -8.82M -380M
Projected Income Statement - Annual - Pathkey.AI Ltd
Logo Pathkey.AI Ltd
Pathkey.AI Ltd, formerly Opyl Limited, is an artificial intelligence (AI) company. The Company leverages data and technology to transform the landscape of clinical trials and medical research. It is a digital health company specializing in leveraging artificial intelligence technologies to elevate clinical trial design and forecast outcomes, empowering clinical researchers, biopharmaceutical corporations, and medical investors to enhance trial design, drug development, and market delivery. Its Social Media Insights solution captures and analyses online public conversations from people living with a medical condition, healthcare professionals, carers, and researchers. Its TrialKey platform provides users access to tailored and actionable steps to address critical trial challenges. The Company specializes in applying AI and predictive analytics to social media to accelerate therapy adoption and market development in the healthcare industry.
Employees
-
Date Price Change Volume
26-10-29 A$0.0160 0.00% 1,020,000
26-10-28 A$0.0160 +6.67% 1,642,057
26-10-27 A$0.0150 -6.25% 1,691,962
26-10-26 A$0.0160 0.00% 542,967
26-10-23 A$0.0160 -11.11% 2,036,977